v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Millions
 12 Months Ended
Feb. 28, 2026
Feb. 28, 2025
Current    
Cash and cash equivalents (note 4) $ 274.7 $ 266.7
Short-term Investments 85.2 71.1
Accounts Receivable, after Allowance for Credit Loss, Current 156.0 173.7
Other receivables (note 5) 7.5 48.4
Income taxes receivable 2.6 1.6
Other current assets (note 5) 42.2 30.0
Total current assets 568.2 591.5
Restricted cash and cash equivalents (note 4) 14.2 13.6
Long-term investments 58.3 58.9
Other long-term assets (note 4) 56.3 76.5
Operating lease right-of-use assets, net 16.7 22.0
Property, plant and equipment, net (note 5) 12.3 13.4
Intangible assets, net (note 5) 40.1 47.3
Goodwill (note 5) 479.1 472.4
Total assets 1,245.2 1,295.6
Current    
Accounts payable 5.5 31.1
Accrued liabilities (note 5) 111.7 126.2
Income taxes payable (note 6) 12.4 25.5
Deferred revenue, current (note 13) 138.5 161.5
Total current liabilities 268.1 344.3
Deferred revenue, non-current 14.1 5.6
Operating lease liabilities 18.8 28.7
Other long-term liabilities 1.7 1.8
Long-term notes (note 7) 196.5 195.3
Total liabilities 499.2 575.7
Capital stock and additional paid-in capital    
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable $ 0.0 $ 0.0
Common Stock, Shares Authorized, Unlimited [Fixed List]
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 587,431,120 voting common shares (February 28, 2025 - 590,230,655) $ 2,924.4 $ 2,976.4
Deficit (2,167.2) (2,237.3)
Accumulated other comprehensive income (loss) (11.2) (19.2)
Total shareholders' equity 746.0 719.9
Total liabilities and shareholders' equity $ 1,245.2 $ 1,295.6